Gamma delta T cells and their role in inflammation related to HIV and aging

Gamma delta T cells promote inflammation in aviremic HIV infection and normal aging

NIH-funded research Boston University Medical Campus · NIH-10862859

This study is looking at how certain immune cells called gamma delta T cells might influence inflammation and gut health in people with HIV who have their virus under control, as well as in older adults, to see how they could be linked to age-related issues like osteoporosis, stroke, and dementia.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBoston University Medical Campus NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-10862859 on NIH RePORTER

What this research studies

This research investigates how gamma delta T cells contribute to inflammation in individuals with HIV who have achieved viral suppression, as well as in the aging population. It focuses on the relationship between these immune cells and age-related diseases, particularly how they may affect intestinal health and overall inflammation. By examining the role of these T cells in the gut, the research aims to understand their impact on conditions such as osteoporosis, stroke, and dementia in older adults. The study employs a combination of clinical assessments and laboratory analyses to explore these mechanisms.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals aged 65 and older who are HIV-positive and have achieved viral suppression.

Not a fit: Patients who are not HIV-positive or those who are younger than 65 years old may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved management of inflammation-related health issues in older adults living with HIV.

How similar studies have performed: Previous research has shown that targeting immune responses can lead to significant improvements in health outcomes for aging populations, suggesting potential success for this approach.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.